Why Is Kairos Pharma Stock Surging On Tuesday?
Kairos Pharma reported strong safety results from a Phase 2 trial of ENV-105 in mCRPC, with no serious toxicities seen in the first 10 patients. read more
Kairos Pharma reported strong safety results from a Phase 2 trial of ENV-105 in mCRPC, with no serious toxicities seen in the first 10 patients. read more
Twilio shares jump after unveiling new AI-driven customer engagement tools, including real-time journeys and EU data residency features. read more
Latest Ratings for SFM Date Firm Action From To Feb 2022 Deutsche Bank Maintains Buy Feb 2022 Credit Suisse Maintains Neutral Feb 2022 Deutsche Bank Maintains Buy View More Analyst Ratings for SFM View the Latest Analyst Ratings read more
Latest Ratings for VIRT Date Firm Action From To Feb 2022 Rosenblatt Maintains Buy Nov 2021 Rosenblatt Maintains Buy Aug 2021 Morgan Stanley Maintains Underweight View More Analyst Ratings for VIRT View the Latest Analyst Ratings read more
Latest Ratings for TFX Date Firm Action From To Feb 2022 Morgan Stanley Maintains Equal-Weight Feb 2022 Raymond James Maintains Outperform Feb 2022 Raymond James Maintains Outperform View More Analyst Ratings for TFX View the Latest Analyst Ratings read more
Rivian partners with Google to launch a new navigation system using Google Maps. This tool enhances EV charging experience and offers real-time recommendations during navigation. read more
Jamie Dimon highlights issues facing the big banks as new players move to stablecoins as a form of payment. read more